Brand News Archive
Horsham, Pa., December 2005
Dudnyk Wins Doctors' Choice Award
Dudnyk has received first place in the urology drug category of the 2005 Doctors' Choice Awards. Dudnyk was cited for its work for the Sanofi-Aventis product Uroxatral®, indicated for benign prostatic hyperplasia. The Doctors' Choice Awards selected more than 300 unsolicited pharmaceutical advertisements and gave 7500 prescribing physicians six categories in which to judge them. Our winning ad received high marks from physicians for execution, clear communication of product information, and appeal.
Horsham, Pa., December 2005
TAP Picks Dudnyk as Agency of Record for Lupron Urology
TAP Pharmaceutical Products, Inc. has selected Dudnyk Healthcare as advertising agency for Lupron Urology. Lupron Depot® (leuprolide acetate for depot suspension) is the market-leading LH-RH analog for the palliative treatment of advanced prostate cancer.
Horsham, Pa., November 2005
Dudnyk wins Gold at RX Club Show
Dudnyk has been honored with a gold award plus six awards of excellence from the 2005 RX Club Show. The ad, titled “End of the Road. But it Isn't,” for the Medtronic, Inc. Pioneer TransAccess Catheter received first place in the full-page category. The RX Club Show, an internationally recognized forum for excellence in pharmaceutical advertising, is judged solely on creative execution.
Horsham, Pa., August 2005
MMRF Taps Dudnyk
The Multiple Myeloma Research Foundation (MMRF) has chosen Dudnyk to collaborate on patient education materials. The publications highlight current research and trials, create greater awareness of the disease, and educate patients and caregivers about the latest treatment options for multiple myeloma, which is cancer of the plasma cells. MMRF is the world's number one private provider of funding for myeloma research.
View Dudnyk ASPECT Magazine Archive
<< Return to current Brand News
